Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema

BMC Health Services Research
Rosanna SpanòAlessandro Barbarino

Abstract

Our research focuses on the co-creation of value in healthcare with reference to a case of hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE). Our work is mainly based on the concept of value co-creation in healthcare. The aim of this study is to assess the impact of an alternative treatment strategy - self-administration - by focusing on treatment outcomes and costs to understand if innovative therapeutic solutions can create value for patients and healthcare systems. This paper compares home-based and hospital-based therapeutic strategies (independent of treatment type) with a cost minimization analysis. It encompasses compliance issues and focuses on both payer and societal perspectives, also benefiting from an operationalization of the service-dominant logic model for healthcare delivery. Data were collected over a 6-month period (August 2014-January 2015) through monthly patient interviews. Archival data were used for variable measurement. Thirty-nine out of 62 patients enrolled in the study, experienced at least one HAE attacks, equally distributed between home and hospital-based strategies. No evidence of correlation between therapeutic strategy and disease severity score (p = 0.351), compliance (p = 0.399),...Continue Reading

References

Nov 30, 2002·BMJ : British Medical Journal·Emma L Simpson, Allan O House
Sep 10, 2004·The Journal of Allergy and Clinical Immunology·Tom BowenJean de Serres
May 7, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Olga RocheMargarita López-Trascasa
Apr 28, 2009·Sociology of Health & Illness·Ian KirkpatrickIndareth Neogy
Aug 28, 2009·The British Journal of Dermatology·A Bygum
Apr 23, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·David A WilsonWilliam E Pullman
Jul 30, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Hilary J LonghurstBruce Zuraw
Sep 3, 2010·Cancer Treatment and Research·Caprice A Knapp, Gwendolyn P Quinn
Dec 15, 2010·The New England Journal of Medicine·Thomas H Lee
Dec 15, 2010·The New England Journal of Medicine·Michael E Porter
May 10, 2011·Allergy and Asthma Proceedings·Marya D ZilberbergGlenn Tillotson
Feb 7, 2012·Lancet·Hilary Longhurst, Marco Cicardi
Jan 4, 2013·The World Allergy Organization Journal·Timothy CraigMarcus Maurer
Apr 24, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Caroline RizkWilliam Yang
May 11, 2013·Biologics : Targets & Therapy·Aasia Ghazi, J Andrew Grant
May 25, 2013·International Archives of Allergy and Immunology·M CicardiH J Longhurst
May 25, 2013·International Archives of Allergy and Immunology·H B BoysenE Aygören-Pürsün
Aug 14, 2013·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Andrea ZanichelliMarcus Maurer
Nov 10, 2013·Acta Dermato-venereologica·Anette Bygum
Sep 10, 2014·International Journal of Medical Informatics·Lynda AndrewsTony Sahama
Nov 15, 2014·Acta Dermato-venereologica·Anette BygumTeresa Caballero
Feb 26, 2015·Allergy and Asthma Proceedings·Sandra C ChristiansenBruce L Zuraw
Mar 12, 2015·Orphanet Journal of Rare Diseases·Andrea ZanichelliAlessandra Zoli
May 1, 2015·International Archives of Allergy and Immunology·Angelica PetraroliMassimo Triggiani
May 20, 2015·Health Services Research·Megan McHughDennis P Scanlon
Oct 28, 2015·BMC Health Services Research·Patrícia RochaFernando Araújo
Nov 12, 2015·Health Services Research·Robert A Berenson, Thomas Rice
Nov 18, 2015·Health Services Research·Mark SchlesingerDale Shaller
Apr 29, 2016·BMC Health Services Research·Josien G TimmermanMiriam M R Vollenbroek-Hutten
May 24, 2016·Antimicrobial Resistance and Infection Control·Anne F G van WoezikJulia E W C van Gemert-Pijnen
Jun 22, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·K H Ken LeePeter J Pronovost
Jul 9, 2016·Clinical Reviews in Allergy & Immunology·Hilary Longhurst, Anette Bygum
Jul 17, 2016·North Carolina Medical Journal·Steven E Wegner
Sep 24, 2016·Patient Preference and Adherence·Emel Aygören-PürsünTeresa Caballero

❮ Previous
Next ❯

Citations

Mar 27, 2019·Expert Opinion on Biological Therapy·Francesca PeregoMarco Cicardi
Jun 17, 2020·Frontiers in Psychology·Natalia RubioMªJesús Yagüe
Apr 4, 2021·International Journal of Environmental Research and Public Health·Marta MarsilioChiara Guglielmetti

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.